A detailed history of High Point Advisor Group LLC transactions in Natera, Inc. stock. As of the latest transaction made, High Point Advisor Group LLC holds 2,026 shares of NTRA stock, worth $279,851. This represents 0.02% of its overall portfolio holdings.

Number of Shares
2,026
Previous 1,986 2.01%
Holding current value
$279,851
Previous $280,000 22.14%
% of portfolio
0.02%
Previous 0.02%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 07, 2025

BUY
$132.23 - $171.87 $5,289 - $6,874
40 Added 2.01%
2,026 $342,000
Q1 2025

May 05, 2025

BUY
$132.63 - $177.0 $62,070 - $82,836
468 Added 30.83%
1,986 $280,000
Q4 2024

Feb 12, 2025

BUY
$117.67 - $174.0 $178,623 - $264,132
1,518 New
1,518 $240,000

Others Institutions Holding NTRA

About Natera, Inc.


  • Ticker NTRA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 96,957,400
  • Market Cap $13.4B
  • Description
  • Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...
More about NTRA
Track This Portfolio

Track High Point Advisor Group LLC Portfolio

Follow High Point Advisor Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of High Point Advisor Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on High Point Advisor Group LLC with notifications on news.